Earnings

Jenscare, with innovative TTVR, releases 2024H1 interim results

2024-08-28 21:00 2179

BEIJING, Aug. 28, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, released interim results for 2024H1 endedJune 30, 2024...

Innovent Announces 2024 Interim Results and Business Updates

2024-08-28 18:42 2795

Strong commercial performance and significant pipeline milestones support sustained growth and innovation SAN FRANSISCO and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and com...

Baozun Announces Second Quarter 2024 Unaudited Financial Results

2024-08-28 18:35 2273

SHANGHAI, Aug. 28, 2024 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2024....

Tigermed Reports 2024 Interim Results

2024-08-28 18:26 1805

HANGZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its int...

Record High Interim Dividend Declared as Net Profit Soars----CNOOC Limited Announced Its 2024 Interim Results

2024-08-28 18:17 1945

HONG KONG, Aug. 28, 2024 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announced today its 2024 interim results. * Making solid progress in reserves and production growth, net production increases by 9.3% year-on-year ("YoY") ...

Fosun Pharma Announces 2024 Interim Results

2024-08-28 18:10 1818

Breakthroughs for Innovative Products Going Overseas with Global Operation Capabilities Continuing to Strengthen SHANGHAI, Aug. 28, 2024 /PRNewswire/ -- On August 27, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH; 02196.HK), announced its o...

Quhuo Reports Unaudited Financial Results for the First Half of 2024

2024-08-28 18:00 1676

BEIJING, Aug. 28, 2024 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo," the "Company," "we" or "our"), a leading gig economy platform focusing on local life services inChina, today reported its unaudited financial results for the six months endedJune 30, 2024. Financial and Operational Highl...

Quhuo Announces Unaudited Financial Results for the First Half of 2024: Precise Strategy Spurs Strong Growth in Mobility Service and Homestay

2024-08-28 18:00 1775

* Revenues from mobility service solutions were RMB100.5 million (US$13.8 million), representing an increase of 71.7% year-over-year. * Quhuo International shipped 815 vehicles under its vehicle export solutions. * The Company has expanded services to 132 cities nationwide, representing a 21....

Kerry Logistics Network Posts 126% Growth in Profit Attributable to the Shareholders, Outperforms the Market in terms of Growth in Core Net Profit

2024-08-28 17:43 1928

HONG KONG, Aug. 28, 2024 /PRNewswire/ -- Kerry Logistics Network Limited ('Kerry Logistics Network' or together with its subsidiaries, the 'Group' or 'KLN Group'; Stock Code 0636.HK) today announced the Group's interim results for the six months ended30 June 2024. Group's Financial Highlights ...

Harbour BioMed Announces 2024 Interim Results

2024-08-28 17:44 1795

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology an...

DPC Dash Ltd Announces 2024 Interim Financial Results

2024-08-28 17:20 3494

Revenues increased to RMB2.04 billion, representing 48.3% year-over-year growth Adjusted net profit reached RMB50.9 million, from an adjusted net loss of RMB17.4 million in the same period of 2023 Store-level operating profit grew by 59.0%; Adjusted group EBITDA increased by 83.7% Added 146 net...

JOYY Reports Second Quarter 2024 Financial Results: Total Revenues up 3.3% Year Over Year, BIGO Achieves Fourth Consecutive Quarter of Growth

2024-08-28 10:24 2423

SINGAPORE, Aug. 28, 2024 /PRNewswire/ -- JOYY Inc. (NASDAQ: YY) ("JOYY" or the "Company"), a global leading technology company, announced its unaudited financial results for the second quarter of 2024. During the second quarter, JOYY's rev...

Yeahka Announces 2024 Interim Results

2024-08-28 10:19 2137

Strengthened Commercialization across Payments and Digital Commerce Ecosystem Remarkable Overseas Expansion Progress  Wider AI Technology Application HONG KONG, Aug. 28, 2024 /PRNewswire/ -- Yeahka Limited ("Yeahka" or the "Company," Stock Code: 9923.HK), a leading payment and digital commerce te...

Jenscare, with innovative TTVR, releases 2024H1 interim results

2024-08-28 09:00 2023

BEIJING, Aug. 28, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, released interim results for 2024H1 endedJune 30, 2024...

Everest Medicines Announces Interim Results for First Half of 2024

2024-08-28 08:00 2131

SHANGHAI, Aug. 28, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half of 2024 a...

Boan Biotech Announces 2024 Half Year Results: Revenue Grows by 39%, Net Profit Increases by RMB 180 Million

2024-08-27 22:55 2486

YANTAI, China, Aug. 27, 2024 /PRNewswire/ -- Boan Biotech (6955.HK) today announced its 2024 half-year results and latest developments. During the reporting period, the company's total revenue was RMB 363 million, up 39% year-over-year. In this, the revenue from product sales wasRMB 332 million,...

AAC Technologies's CFO Guo Dan: Expects 15% Growth in Revenue of Main Business while the Growth of the Group May Exceeds 30% After PSS Consolidation

2024-08-27 21:20 2358

HONG KONG, Aug. 27, 2024 /PRNewswire/ -- On August 22, AAC Technologies (02018.HK) held its 2024 interim results presentation inHong Kong, delivering remarkably impressive performance. (Left) Ms....

Keymed Biosciences Announces Interim Results for First Half of 2024

2024-08-27 21:10 2035

CHENGDU, China , Aug. 27, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced its interim results for the first half of 2024, along with a corporate update.  Rapid development of our pipeline products Stapokibart (CM310) (IL-4Rα antibody) * In June 2024, the long-term e...

Xuan Wu Cloud Announces Interim Results for 2024

2024-08-27 19:45 2114

Revenue Increased by 22.2% and Net Loss Reduced by Nearly 70% year-on-year * In the first half of 2024, Xuan Wu Cloud achieved total revenue of RMB 647.5 million, reflecting steady growth of 22.2% compared to the same period last year. Net loss was significantly reduced by 69.5% toRMB 6.1 milli...

CNFinance Announces First Half of 2024 Unaudited Financial Results

2024-08-27 18:39 3551

GUANGZHOU, China, Aug. 27, 2024 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider inChina, today announced its unaudited financial results for the first half of 2024 endedJune 30, 2024. First Half of 2024 Operationa...

12345678 ... 285